SI1185255T1 - Retinoprotektivna oftalmološka zdravila, ki obsegajo ramipril ali ramiprilat - Google Patents
Retinoprotektivna oftalmološka zdravila, ki obsegajo ramipril ali ramiprilatInfo
- Publication number
- SI1185255T1 SI1185255T1 SI200031031T SI200031031T SI1185255T1 SI 1185255 T1 SI1185255 T1 SI 1185255T1 SI 200031031 T SI200031031 T SI 200031031T SI 200031031 T SI200031031 T SI 200031031T SI 1185255 T1 SI1185255 T1 SI 1185255T1
- Authority
- SI
- Slovenia
- Prior art keywords
- ramiprilat
- ramipril
- medicine
- visual
- acuity
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/10—Ophthalmic agents for accommodation disorders, e.g. myopia
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Ophthalmology & Optometry (AREA)
- Epidemiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Steroid Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Saccharide Compounds (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| TN99122 | 1999-06-16 | ||
| FR9915359A FR2794975A1 (fr) | 1999-06-16 | 1999-12-06 | Medicaments opthalmologiques neuro et retino-protecteurs |
| EP00951603A EP1185255B1 (fr) | 1999-06-16 | 2000-06-16 | MEDICAMENTS OPHTALMOLOGIQUES RETINO-PROTECTEURS comprenant du ramipril ou du ramiprilat |
| PCT/FR2000/001679 WO2000076499A2 (fr) | 1999-06-16 | 2000-06-16 | Medicaments ophtalmologiques neuro-et retino-protecteurs |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SI1185255T1 true SI1185255T1 (sl) | 2009-08-31 |
Family
ID=26235177
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SI200031031T SI1185255T1 (sl) | 1999-06-16 | 2000-06-16 | Retinoprotektivna oftalmološka zdravila, ki obsegajo ramipril ali ramiprilat |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US7049340B1 (sl) |
| EP (1) | EP1185255B1 (sl) |
| JP (1) | JP2003501461A (sl) |
| AT (1) | ATE424819T1 (sl) |
| AU (1) | AU6449000A (sl) |
| BR (1) | BR0011714A (sl) |
| CA (1) | CA2376909A1 (sl) |
| CZ (1) | CZ20014516A3 (sl) |
| DE (1) | DE60041765D1 (sl) |
| DK (1) | DK1185255T3 (sl) |
| ES (1) | ES2324200T3 (sl) |
| HU (1) | HUP0201478A3 (sl) |
| MA (1) | MA26798A1 (sl) |
| MX (1) | MXPA01012907A (sl) |
| NO (1) | NO20016088L (sl) |
| PL (1) | PL352365A1 (sl) |
| SI (1) | SI1185255T1 (sl) |
| SK (1) | SK18772001A3 (sl) |
| TR (1) | TR200103665T2 (sl) |
| WO (1) | WO2000076499A2 (sl) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2826276A1 (fr) * | 2001-06-20 | 2002-12-27 | Raouf Rekik | Administration des inhibiteurs de l'enzyme de conversion de l'angiotensine dans les degradations visuelles des sujets ages dues a la presbytie |
| WO2007134136A2 (en) * | 2006-05-09 | 2007-11-22 | Braincells, Inc. | Neurogenesis by modulating angiotensin |
| US7858611B2 (en) | 2006-05-09 | 2010-12-28 | Braincells Inc. | Neurogenesis by modulating angiotensin |
| TNSN08110A1 (en) * | 2008-03-11 | 2009-07-14 | Rekik Raouf Dr | Drug delivery to the anterior and posterior segment of the eye from drops |
| TN2010000566A1 (en) * | 2010-12-03 | 2012-05-24 | Rekik Raouf | Folic acid - ramipril combination : cell protective neuroprotective and retinoprotective ophtalmologic drugs |
| RU2471454C2 (ru) * | 2010-12-14 | 2013-01-10 | Валерий Викторович Педдер | Способ лечения дистрофических заболеваний сетчатки глаза |
| JP6238977B2 (ja) * | 2012-06-29 | 2017-11-29 | ラオフ・レキク | 視神経症または先天性視神経萎縮を治療するためのアンギオテンシン変換酵素阻害薬 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3381850D1 (de) | 1982-12-27 | 1990-10-04 | Schering Corp | Pharmazeutische zusammensetzung. |
| DE3410732A1 (de) | 1984-03-23 | 1985-09-26 | Hoechst Ag, 6230 Frankfurt | Methode zur behandlung des glaukoms |
| US4656188A (en) | 1985-10-09 | 1987-04-07 | Merck & Co., Inc. | Ace inhibitors in macular degeneration |
| JPH05306296A (ja) * | 1992-04-24 | 1993-11-19 | Marino Forum 21 | 魚類由来ペプチドとその製法 |
| WO1999036062A1 (en) | 1998-01-16 | 1999-07-22 | Alcon Laboratories, Inc. | Topical administration of angiotensin-converting enzyme inhibitors |
-
2000
- 2000-06-16 CA CA002376909A patent/CA2376909A1/fr not_active Abandoned
- 2000-06-16 CZ CZ20014516A patent/CZ20014516A3/cs unknown
- 2000-06-16 TR TR2001/03665T patent/TR200103665T2/xx unknown
- 2000-06-16 PL PL00352365A patent/PL352365A1/xx not_active Application Discontinuation
- 2000-06-16 SK SK1877-2001A patent/SK18772001A3/sk unknown
- 2000-06-16 JP JP2001502832A patent/JP2003501461A/ja active Pending
- 2000-06-16 BR BR0011714-5A patent/BR0011714A/pt not_active Application Discontinuation
- 2000-06-16 EP EP00951603A patent/EP1185255B1/fr not_active Expired - Lifetime
- 2000-06-16 WO PCT/FR2000/001679 patent/WO2000076499A2/fr not_active Application Discontinuation
- 2000-06-16 ES ES00951603T patent/ES2324200T3/es not_active Expired - Lifetime
- 2000-06-16 AU AU64490/00A patent/AU6449000A/en not_active Abandoned
- 2000-06-16 DE DE60041765T patent/DE60041765D1/de not_active Expired - Lifetime
- 2000-06-16 DK DK00951603T patent/DK1185255T3/da active
- 2000-06-16 AT AT00951603T patent/ATE424819T1/de active
- 2000-06-16 MX MXPA01012907A patent/MXPA01012907A/es unknown
- 2000-06-16 SI SI200031031T patent/SI1185255T1/sl unknown
- 2000-06-16 US US10/018,235 patent/US7049340B1/en not_active Expired - Lifetime
- 2000-06-16 HU HU0201478A patent/HUP0201478A3/hu unknown
-
2001
- 2001-12-10 MA MA26439A patent/MA26798A1/fr unknown
- 2001-12-13 NO NO20016088A patent/NO20016088L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| US7049340B1 (en) | 2006-05-23 |
| MXPA01012907A (es) | 2003-06-24 |
| DE60041765D1 (de) | 2009-04-23 |
| HUP0201478A2 (hu) | 2002-11-28 |
| ES2324200T3 (es) | 2009-08-03 |
| EP1185255A2 (fr) | 2002-03-13 |
| HUP0201478A3 (en) | 2004-05-28 |
| AU6449000A (en) | 2001-01-02 |
| DK1185255T3 (da) | 2009-07-06 |
| EP1185255B1 (fr) | 2009-03-11 |
| CZ20014516A3 (cs) | 2002-05-15 |
| SK18772001A3 (sk) | 2002-04-04 |
| NO20016088L (no) | 2002-02-12 |
| NO20016088D0 (no) | 2001-12-13 |
| BR0011714A (pt) | 2002-03-05 |
| TR200103665T2 (tr) | 2002-10-21 |
| WO2000076499A2 (fr) | 2000-12-21 |
| CA2376909A1 (fr) | 2000-12-21 |
| PL352365A1 (en) | 2003-08-25 |
| ATE424819T1 (de) | 2009-03-15 |
| JP2003501461A (ja) | 2003-01-14 |
| WO2000076499A3 (fr) | 2001-05-17 |
| MA26798A1 (fr) | 2004-12-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA989385B (en) | Methods for treating hypercoagulable states or acquired protein C deficiency. | |
| EP1118325A3 (en) | Drug delivery systems containing microtubule stabilizing agents and the use of said agents in the manufacture of a medicament for treating atherosclerosis or restenosis | |
| CA2391539A1 (en) | Use of poly(diallylamine) polymers | |
| WO2004028570A3 (en) | A method for treating severe tinnitus | |
| EP0771565A3 (en) | Angiogenesis inhibitor | |
| WO2001019334A3 (en) | Pharmaceutical solutions of levosimendan | |
| EP1074258A3 (en) | Methods and compositions for treating diseases and conditions of the eye | |
| AU696954B2 (en) | Antithrombotic and non-hemorrhagic heparin-based compositions, process for their preparation and therapeutic applications | |
| SI1185255T1 (sl) | Retinoprotektivna oftalmološka zdravila, ki obsegajo ramipril ali ramiprilat | |
| Egorov et al. | Histochrome, a new antioxidant, in the treatment of ocular diseases | |
| Boda et al. | Low molecular weight heparin as thromboprophylaxis in familial thrombophilia during the whole period of pregnancy | |
| GB8917323D0 (en) | Methods and pharmaceutical compositions for the treatment of ophthalmic diseases | |
| Akkan et al. | Penetration of topically applied ciprofloxacin, norfloxacin and ofloxacin into the aqueous humor of the uninflamed human eye | |
| Meyers et al. | Pharmacokinetics of cefamandole in patients with renal failure | |
| WO1998024898A3 (en) | Therapeutic composition comprising the kal protein and use of the kal protein | |
| WO2003006002A8 (en) | Compositions and methods of administering tubulin binding agents for the treatment of ocular diseases | |
| ATE224727T1 (de) | Faktor xiii zur behandlung von hautwunden | |
| AU2001223953A1 (en) | Use of l-carnitine as stabilizing agent of proteins | |
| WO1999006438A3 (en) | Compounds with anti-ks and anti-hiv activity | |
| WO2007036920A3 (en) | Therapeutic use of polyanhydroglucronic acid | |
| CY1110476T1 (el) | Οφθαλμολογικα φαρμακα προστατευτικα του αμφιβληστροειδους τα οποια περιεχουν ραμιπριλη ή ραμιπριλατη | |
| WO2003011119A3 (en) | Methods and compositions for diagnosis and treatment of vascular conditions | |
| CA2159609A1 (en) | Factor xiii for treatment of skin wounds | |
| RU93021719A (ru) | Способ лечения отслойки сетчатки | |
| UA33293A (uk) | Спосіб лікування травматичних ушкоджень рогової оболонки |